[HTML][HTML] Margin assessment in soft tissue sarcomas: review of the literature
A Sambri, E Caldari, M Fiore, R Zucchini, C Giannini… - Cancers, 2021 - mdpi.com
Simple Summary Many classifications to assess margins status for soft tissue sarcomas are
reported in the literature. Most of the series are heterogeneous and variable in size, making …
reported in the literature. Most of the series are heterogeneous and variable in size, making …
[HTML][HTML] Surgical margins in the management of extremity soft tissue sarcoma
M Endo, PP Lin - Chinese clinical oncology, 2018 - cco.amegroups.org
Standard treatment of localized soft tissue sarcoma should include surgical resection, which
can be performed alone or in combination with perioperative radiotherapy and/or …
can be performed alone or in combination with perioperative radiotherapy and/or …
Analysis of margin classification systems for assessing the risk of local recurrence after soft tissue sarcoma resection
KR Gundle, L Kafchinski, S Gupta… - Journal of Clinical …, 2018 - eprints.gla.ac.uk
Purpose: To compare the ability of margin classification systems to determine local
recurrence (LR) risk after soft tissue sarcoma (STS) resection. Methods: Two thousand two …
recurrence (LR) risk after soft tissue sarcoma (STS) resection. Methods: Two thousand two …
Fluorescence-guided visualization of soft-tissue sarcomas by targeting vascular endothelial growth factor A: a phase 1 single-center clinical trial
PJ Steinkamp, BK Pranger, MF Li… - Journal of Nuclear …, 2021 - Soc Nuclear Med
Resection of soft-tissue sarcoma (STS) is accompanied by a high rate of tumor-positive
surgical margins (14%–34%), which potentially lead to decreased disease-free survival …
surgical margins (14%–34%), which potentially lead to decreased disease-free survival …
[HTML][HTML] A prediction model for treatment decisions in high-grade extremity soft-tissue sarcomas: personalised sarcoma care (PERSARC)
VM van Praag, AJ Rueten-Budde, LM Jeys… - European Journal of …, 2017 - Elsevier
Background To support shared decision-making, we developed the first prediction model for
patients with primary soft-tissue sarcomas of the extremities (ESTS) which takes into account …
patients with primary soft-tissue sarcomas of the extremities (ESTS) which takes into account …
[HTML][HTML] The prognostic impact of unplanned excisions in a cohort of 728 soft tissue sarcoma patients: a multicentre study
MA Smolle, PU Tunn, E Goldenitsch, F Posch… - Annals of surgical …, 2017 - Springer
Background Unplanned excisions (UE) of soft tissue sarcomas (STS) carry a high risk for
local recurrence (LR) due to marginal/intralesional resections. However, there are reports …
local recurrence (LR) due to marginal/intralesional resections. However, there are reports …
[HTML][HTML] The effect of resection margin on local recurrence and survival in high grade soft tissue sarcoma of the extremities: how far is far enough?
Simple Summary In soft tissue sarcomas the width of surgical margins after resection
determines the extent of surgery and the function after resection. But how far is really …
determines the extent of surgery and the function after resection. But how far is really …
MRI of Soft-Tissue Tumors: What to Include in the Report
MRI serves as a critical step in the workup, local staging, and treatment planning of extremity
soft-tissue masses. For the radiologist to meaningfully contribute to the management of soft …
soft-tissue masses. For the radiologist to meaningfully contribute to the management of soft …
[HTML][HTML] Surgical treatment and long-term outcomes of low-grade myofibroblastic sarcoma: a single-center case series of 15 patients
JH Kim, W Choi, HS Cho, KS Lee, JK Park… - World Journal of Surgical …, 2021 - Springer
Background Low-grade myofibroblastic sarcoma (LGMS) is a poorly studied, rare, soft tissue
sarcoma. LGMS is characterized by a low malignancy potential, tendency for local …
sarcoma. LGMS is characterized by a low malignancy potential, tendency for local …
[HTML][HTML] Characterizing the immune microenvironment of malignant peripheral nerve sheath tumor by PD-L1 expression and presence of CD8+ tumor infiltrating …
E Shurell, AS Singh, JG Crompton, S Jensen, Y Li… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Background Malignant peripheral nerve sheath tumor (MPNST) is an aggressive sarcoma
with few treatment options. Tumor immune state has not been characterized in MPNST, and …
with few treatment options. Tumor immune state has not been characterized in MPNST, and …